×

The Rosen Law Firm Announces Investigation of Securities Claims Against Star Scientific, Inc.

NEW YORK, Jan. 24, 2013 (GLOBE NEWSWIRE) -- The Rosen Law Firm announces that it is investigating potential securities fraud claims against Star Scientific, Inc. resulting from allegations that the Company may have issued materially inaccurate statements about the involvement of the prestigious Johns Hopkins University in one of STSI's clinical studies.

Throughout the course of 2012, STSI had been touting its relationship with Johns Hopkins University, who was purportedly conducting studies relating to STSI's product, Anatabloc. For example, a press release dated June 27, 2012 stated that research had been conducted by "[t]he independently funded research team at Johns Hopkins [....]" In a Press Release dated January 7, 2013 announcing the results of STSI's clinical trials, STSI quoted Dr. Paul Ladenson of Johns Hopkins University, but omitted mention of Johns Hopkins University.

On January 23, 2013, TheStreet.com published an article refuting claims that John's Hopkins was conducting clinical trials with STSI. In the article, a Johns Hopkins spokesperson is quoted as responding to Dr. Ladenson's claim by stating: "We do have guidelines about such things and he [Ladenson] is in violation here." The Johns Hopkins spokesperson purportedly added that Johns Hopkins had started an inquiry into the conduct. As a result of this adverse news, the price of STSI stock fell on January 23, 2013, damaging investors.

The Rosen Law Firm is investigating a securities class action lawsuit on behalf of STSI investors. If you purchased STSI stock before January 23, 2013, please visit the website at http://rosenlegal.com for more information. You may also contact Jonathan Horne, Esq., or Phillip Kim, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at jhorne@rosenlegal.com or pkim@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

CONTACT: Laurence Rosen, Esq. Phillip Kim, Esq. Jonathan Horne, Esq. The Rosen Law Firm P.A. 275 Madison Avenue 34th Floor New York, New York 10016 Tel: (212) 686-1060 Weekend Tel: (917) 562-8616 Toll Free: 1-866-767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com jhorne@rosenlegal.com pkim@rosenlegal.com www.rosenlegal.comSource: The Rosen Law Firm PA PC